MannKind Corporation (MNKD)
MNKD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.05
-2.56% on the day
Market cap
$980.7M
Small cap
Revenue · 2025
$349.0M
+22.2% on 2024
Net income · 2025
$5.9M
1.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | MNKD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2004 |
| SEC CIK | 0000899460 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $349.0M |
| Net income | $5.9M |
| Operating income | $38.8M |
| Net margin | 1.7% |
| Operating margin | 11.1% |
| Revenue growth | +22.2% |
| Cash | $74.9M |
| Total assets | $792.2M |
| P/E (computed) | 167.3× |
| P/S (computed) | 2.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2026-08-21 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-21 |
| Latest proxy | DEFA14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -12.5% |
| 1 month | -15.2% |
| 3 months | -25.2% |
| Year to date | -46.7% |
| 1 year | -40.8% |
| From 52-week high | -51.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SVRA | Savara Inc. | $4.78 | -1.24% | $982.1M |
| OPK | OPKO Health Inc. | $1.32 | -4.35% | $985.2M |
| AKTS | Aktis Oncology Inc. | $16.64 | -4.04% | $925.5M |
| LTGO | Latigo Biotherapeutics Inc. | $15.71 | -1.94% | $1.0B |
| JANX | Janux Therapeutics Inc. | $17.18 | -5.34% | $1.1B |
| AVLN | Avalyn Pharma Inc. | $23.74 | -4.27% | $1.1B |
| HROW | Harrow Inc. | $28.24 | -2.99% | $1.1B |
| MLTX | MoonLake Immunotherapeutics | $10.41 | -2.53% | $886.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier